Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Slutplattan FEMVO 115462 AB
AB
Dissolved
Org 5592523368
Manufacture of basic pharmaceutical products
· NACE 2110
Est. 2020
1 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of basic pharmaceutical products
/
Slutplattan FEMVO 115462 AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
1M
2021
EBITDA
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
Income statement
SEK thousands
Item
2020
2021
Revenue
78
663
Staff expenses
—
—
EBITDA
−33
391
Depreciation & amort.
−0
−0
EBIT
−33
Balance sheet
SEK thousands
Item
2020
2021
Total assets
97
578
Equity
17
333
Long-term debt
0
0
Short-term debt
80
244
Total debt
80
Financial ratios
5-year trend
EBITDA margin
59.0%
This company
15.8%
Market median
+273% vs market
2020
2021
Equity ratio
57.6%
Annual reports & filings
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-04-01 – 2020-12-31
More on Slutplattan FEMVO 115462 AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
391
Net financials
—
—
Profit before tax
−33
391
Tax
−0
−74
Net profit
−33
317
244
This company
38.2%
Market median
+51% vs market
2020
2021
Return on equity
95.2%
This company
18.4%
Market median
+417% vs market
2020
2021
Net profit margin
47.8%
This company
8.1%
Market median
+490% vs market
2020
2021
Asset turnover
1.15×
This company
1.12×
Market median
+3% vs market
2020
2021
Debt / equity
0.74×
This company
0.62×
Market median
+19% vs market
2020
2021
View
PDF
